Edwards Lifesciences Balance Sheet
NYSE: EWHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Edwards Lifesciences financial position
At the end of fiscal 2025, Edwards Lifesciences reported total assets of $13.70 billion, up 4.9% from a year earlier against total liabilities of $3.36 billion. Shareholders' equity stood at $10.34 billion, or 75.5% of assets. The company held $2.94 billion in cash and equivalents against $598.3 million of debt, a net cash position of $2.34 billion.
The current ratio (current assets divided by current liabilities) was 3.72, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.06.
Summary generated from market data by MetaCap's automated system. Methodology
Edwards Lifesciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.94B | 3.05B | 1.13B | 769.00M | 862.80M | 1.18B | 1.18B | 714.10M | 818.30M | 930.10M |
| Short-Term Investments | 1.29B | 930.70M | 500.50M | 446.30M | 604.00M | 219.40M | 337.80M | 242.40M | 519.20M | 341.00M |
| Receivables | 659.60M | 609.10M | 771.50M | 643.00M | 582.20M | 514.60M | 543.60M | 456.90M | 438.70M | 365.50M |
| Inventory | 1.13B | 1.09B | 903.50M | 875.50M | 726.70M | 802.30M | 640.90M | 607.00M | 554.90M | 396.60M |
| Total Current Assets | 6.74B | 6.29B | 4.04B | 3.10B | 3.18B | 3.09B | 2.98B | 2.29B | 2.55B | 2.24B |
| Property, Plant & Equipment | 1.81B | 1.69B | 1.59B | 1.63B | 1.55B | 1.40B | 1.06B | 867.50M | 679.70M | 580.00M |
| Goodwill | 1.77B | 1.78B | 1.15B | 1.06B | 1.17B | 1.17B | 1.17B | 1.11B | 1.13B | 626.10M |
| Intangible Assets | 1.13B | 1.18B | 399.40M | 285.20M | 323.60M | 331.40M | 336.50M | 343.20M | 468.00M | 204.80M |
| Long-Term Investments | 278.60M | 307.90M | 583.90M | 1.24B | 1.83B | 801.60M | 585.50M | 506.30M | 567.00M | 532.10M |
| Total Assets | 13.70B | 13.06B | 9.36B | 8.29B | 8.50B | 7.24B | 6.49B | 5.32B | 5.67B | 4.51B |
| Accounts Payable | 227.50M | 197.40M | 186.60M | 201.90M | 204.50M | 196.50M | 180.40M | 134.00M | 116.60M | 97.10M |
| Short-Term Debt | — | — | — | — | — | — | — | 0 | 598.00M | 0 |
| Total Current Liabilities | 1.81B | 1.51B | 1.20B | 1.02B | 1.03B | 893.90M | 902.40M | 876.60M | 1.42B | 532.50M |
| Long-Term Debt | 598.30M | 597.70M | 597.00M | 596.30M | 595.70M | 595.00M | 594.40M | 593.80M | 438.40M | 822.30M |
| Total Liabilities | 3.36B | 2.99B | 2.64B | 2.49B | 2.67B | 2.66B | 2.34B | 2.18B | 2.71B | 1.89B |
| Shareholders' Equity | 10.34B | 10.00B | 6.65B | 5.81B | 5.84B | 4.57B | 4.15B | 3.14B | 2.96B | 2.62B |
| Retained Earnings | 14.24B | 13.17B | 8.99B | 7.59B | 6.07B | 4.57B | 3.74B | 2.69B | 1.96B | 3.91B |
| Total Debt | 598.30M | 597.70M | 597.00M | 596.30M | 595.70M | 595.00M | 594.40M | 593.80M | 1.04B | 822.30M |
| Net Cash (Debt) | 3.63B | 3.38B | 1.04B | 619.00M | 871.10M | 807.60M | 922.50M | 362.70M | 301.10M | 448.80M |
| Shares Outstanding | 580.70M | 588.60M | 601.10M | 608.30M | 624.10M | 624.30M | 209.10M | 207.70M | 209.70M | 211.60M |
This table shows 10 annual periods of Edwards Lifesciences's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow EW's reporting calendar. What is a balance sheet?